Evolution of patients with ulcerative colitis who withdraw the maintenance treatment with mesalazine

被引：0
|
作者：
Algaba, A. [1 ]
Guerra, I. [1 ]
Bonillo, D. [1 ]
Hernandez, M. [1 ]
Granja, A. [1 ]
Bernal, P. [1 ]
Berrmejo, F. [1 ]
机构：
[1] Hosp Univ Fuenlabrada, Gastroenterol, Madrid, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P412
引用
收藏
页码：S306 / S307
页数：2
相关论文
共 50 条
  • [21] Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
    Bei Ye
    Daniel R van Langenberg
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2015, 6 (04) : 137 - 144
  • [22] Combined oral and topical mesalazine treatment for extensive ulcerative colitis
    Alan C Moss
    Adam S Cheifetz
    Mark A Peppercorn
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 290 - 293
  • [23] Reply to Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis
    Pedersen, Natalia
    Munkholm, Pia
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (08) : E15 - E16
  • [24] Combined oral and topical mesalazine treatment for extensive ulcerative colitis
    Moss, Alan C.
    Cheifetz, Adam S.
    Peppercorn, Mark A.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (05): : 290 - 293
  • [25] COMPARISON OF MESALAZINE WITH SULPHASALAZINE IN PROPHYLACTIC TREATMENT OF ULCERATIVE-COLITIS
    PORRO, GB
    ARDIZZONE, S
    FASOLI, R
    PETRILLO, M
    DESIDERI, S
    GUT, 1989, 30 (10) : A1467 - A1467
  • [26] Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis
    Kruis, W
    Brandes, JW
    Schreiber, S
    Theuer, D
    Krakamp, B
    Schutz, E
    Otto, P
    Lorenz-Mayer, H
    Ewe, K
    Judamaier, G
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 707 - 715
  • [27] Maintenance of clinical remission with MMX® mesalazine 2.4 g/day in patients with mild-to-moderate ulcerative colitis, irrespective of prior treatment
    Kane, S.
    Solomon, D.
    Palmen, M.
    Barrett, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A91 - A91
  • [28] MMX mesalazine is well tolerated during 12 months' maintenance treatment of mild-to-moderate ulcerative colitis
    Kamm, M. A.
    Lichtenstein, G. R.
    Sandborn, W. J.
    Barrett, K.
    Joseph, R. E.
    GUT, 2007, 56 : A113 - A113
  • [29] Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis
    P. Vernia
    G. Monteleone
    G. Grandinetti
    G. Villotti
    E. Di Giulio
    G. Frieri
    A. Marcheggiano
    F. Pallone
    R. Caprilli
    A. Torsoli
    Digestive Diseases and Sciences, 2000, 45 : 976 - 981
  • [30] Health Maintenance in Patients with Ulcerative Colitis
    Harper, Jason
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2020, 49 (04) : 809 - +
12345